Clinical Trials Sponsored by Argon Medical Devices

Total 1207 results

Abbott Medical Devices

Completed

The LEADLESS Observational Study

Indications for VVI(R) Pacemaker

United Kingdom, Italy, Germany, Spain, France, Netherlands, Czechia
Abbott Medical Devices

Completed

Quartet Lead and Resynchronization Therapy Options III (QUARTO_III) (QUARTO_III)

Heart Failure

Spain
Abbott Medical Devices

Completed

The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study (PIVSD PAS)

Post-Infarction Ventricular Septal Defect

United States
Abbott Medical Devices

Completed

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

Coronary Artery Lesions

United States
Abbott Medical Devices

Completed

TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study (TactiCathPAS)

Paroxysmal Atrial Fibrillation

United States
Abbott Medical Devices

Completed

Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS) (HOMEOSTASIS)

Heart Failure

United States, Australia, New Zealand
Abbott Medical Devices

Terminated

IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTensioN (EnligHTN-II)

Hypertension | Blood Pressure

Netherlands, Australia, United Kingdom, New Zealand, France, Norway, Germany, Italy, Greece, Spain, Sweden
Abbott Medical Devices

Completed

LSI (Lesion Index) Workflow Observational Study

Paroxysmal Atrial Fibrillation

United States, Italy, Germany, Japan, Spain
Abbott Medical Devices

Completed

XIENCE 28 Global Study

Coronary Artery Disease | Renal Insufficiency | Anemia | Thrombocytopenia | Coagulation Disorder | Stroke, Ischemic | Stroke Hemorrhagic | Bleeding Disorder | Hematological Disease

China, Spain, Belgium, Germany, Portugal, Switzerland, Hong Kong, United Kingdom, Austria, Italy, Netherlands, Singapore, Taiwan
Abbott Medical Devices

Completed

MultiPoint Pacing™ Post Market Study (MPP-PMS)

Heart Failure

United States, Japan, Argentina, Colombia
Abbott Medical Devices

Completed

Trifecta™ Long Term Follow-Up (LTFU) Study

Aortic Valve Stenosis | Aortic Valve Insufficiency | Aortic Valve Incompetence | Aortic Valve Regurgitation

United States, Canada
Abbott Medical Devices

Completed

Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therapy During the Trial (DELIVERY)

Chronic, Intractable Pain of the Trunk and/or Lower Limbs

United States, Australia, Netherlands, Sweden, Germany, Italy, Austria
Abbott Medical Devices

Completed

Post-market Study of Multi-Vector Left Ventricular Lead Performance in Chinese Patients With Chronic Heart Failure (MVLV)

Chronic Heart Failure

China
Abbott Medical Devices

Completed

Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead

Adverse Effect of MRI on an Implanted Pacemaker Lead | Adverse Effect of MRI on an Implanted Pacemaker

United States, Netherlands, Australia, Belgium, Finland
Abbott Medical Devices

Completed

HBP Device EGM Data Collection

Heart Failure | Sick Sinus Syndrome | AV Block

United States
Abbott Medical Devices

Completed

PREMIUM Migraine Trial

Patent Foramen Ovale | Migraine Headaches

United States
Abbott Medical Devices

Terminated

Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance

Heart Block | Ventricular Dysfunction | Atrioventricular Block | Sick Sinus Syndrome

Switzerland
Abbott Medical Devices

Completed

Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI (AMICRO)

STEMI | Multi Vessel Coronary Artery Disease

Italy
Abbott Medical Devices

Completed

Observational Study of OCT in a Patients Undergoing FFR (ILUMIEN I)

Coronary Artery Disease

United Kingdom, Japan, United States, France, Canada, Belgium, Australia, Italy, China, Czechia, Austria, Germany, Netherlands, Spain
Abbott Medical Devices

Completed

XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study (XP China SAS)

Myocardial Infarction | Coronary Artery Disease | Cardiovascular Disease | Coronary Heart Disease | Stent Thrombosis | Coronary Restenosis | Vascular Disease | Angioplasty

United States
Abbott Medical Devices

Completed

A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence (RDN+AF)

Hypertension | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation

Germany
Abbott Medical Devices

Completed

EnSite Precision Observational Study

Cardiac Arrhythmia

United States
Abbott Medical Devices

Completed

Clinical Evaluation of Mediguide System in Cardiac Resynchronization Therapy (CRT) Implants

Heart Failure
Abbott Medical Devices

Terminated

A Post Market Cohort With the Spinal Modulation Neurostimulator System in Peripheral Neuropathy

Peripheral Neuropathy

Germany
Abbott Medical Devices

Terminated

Study Protocol/ Registry of MultiPoint™ Pacing in Brazil

Heart Failure, Unspecified

Brazil
Abbott Medical Devices

Completed

A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular Arrhythmias (inSighT)

Coronary Artery Disease

Germany
Abbott Medical Devices

Completed

Accent Cardiac MRI Study (Accent Cardiac)

Bradycardia

Thailand, Hong Kong, Malaysia, India, China
Abbott Medical Devices

Completed

QuickFlex Micro Left Ventricular Lead Post Approval Study

Heart Failure

United States
Abbott Medical Devices

Completed

AF Substrate Mapping and Guided Ablation

Persistent Atrial Fibrillation

Italy
Abbott Medical Devices

Terminated

A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimulator System in Chronic Post Surgical Pain

Chronic Post Surgical Pain

Netherlands
Abbott Medical Devices

Completed

Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study (Promote Q)

Heart Failure

United States
Abbott Medical Devices

Completed

Irrigated Ablation System Evaluation for Atrial Fibrillation (AF) (IRASE-AF)

Paroxysmal Atrial Fibrillation

United States, Korea, Republic of, Canada
Abbott Medical Devices

Completed

TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR)

Paroxysmal Atrial Fibrillation

United States
Abbott Medical Devices

Completed

AVAI: Atrial Ventricular Arrythmia Incidence (AVAI)

Atrial Fibrillation | Ventricular Tachycardia

Spain
Abbott Medical Devices

Terminated

AGIR Study: Angio-Seal in Interventional Radiology (AGIR)

Vascular Access Complication

Spain, Portugal
Abbott Medical Devices

Completed

Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the Treatment of Typical Atrial Flutter (AFL)

Typical Atrial Flutter

United States, Canada
Abbott Medical Devices

Completed

Aortic Valve Replacement With Trifecta(TM)

Aortic Valve Stenosis | Aortic Valve Insufficiency | Regurgitation, Aortic Valve | Aortic Valve Incompetence

United States
Abbott Medical Devices

Completed

Safety and Efficacy Study of the QuickFlex Micro Model 1258T Left Heart Pacing Lead

Heart Failure

United States
Abbott Medical Devices

Completed

Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial

Cryptogenic Stroke

United States, Canada
Abbott Medical Devices

Completed

Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter (FLEXION-AFL)

Typical Atrial Flutter

United States, Canada
Abbott Medical Devices

Completed

More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges (MORE-CRT)

Heart Failure | Perioperative/Postoperative Complications | Postoperative Cardiac Complication | Left Ventricular Cardiac Dysfunction | Inappropriate Phrenic Nerve Stimulation

Spain, United Kingdom, Netherlands, France, Israel, Finland, Canada, Belgium, Germany, Italy, India, Poland, Switzerland
Abbott Medical Devices

Completed

Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve

Heart Valve Diseases

United States
Abbott Medical Devices

Terminated

Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia (STAR-VT)

Monomorphic Ventricular Tachycardia

United States, United Kingdom, France, Australia, Italy
Abbott Medical Devices

Completed

EnSite Precision 2.1 Feasibility Study

Arrhythmias
Abbott Medical Devices

Completed

Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Patients (EnligHTN-I)

Hypertension

Australia, Greece
Abbott Medical Devices

Completed

Angio-Seal Interventional Radiology (IR) Registry

Diagnostic and/or Interventional Radiology Procedures

United States
Abbott Medical Devices

Completed

'Effect of CRT on Defibrillation Threshold Estimates' Study

Sudden Cardiac Death

United States
Abbott Medical Devices

Completed

Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients

Heart Failure

United States
Abbott Medical Devices

Completed

Efficacy and Safety Study on Agilis NxT Introducer in AF Patients (AGILIS)

Atrial Fibrillation

Germany
Abbott Medical Devices

Completed

Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment

Bradycardia

Austria

Clinical Trials Sponsored by Argon Medical Devices

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations